NCT02767167

Brief Summary

Iodine is an essential trace element necessary for the synthesis of thyroid hormones which are critical for human growth and development throughout the lifecycle. Iodine is particularly important during pregnancy and infancy for brain and neurological development. Severe iodine deficiency during pregnancy can cause severe mental impairment and stillbirth while mild-to-moderate deficiency has been associated with impaired infant development. As such, pregnant women and women of child-bearing age are particularly vulnerable to the effects of iodine deficiency. Globally, 241 million (30%) school aged children are iodine deficient. Historically, the UK and Ireland were believed to be iodine sufficient but concern has been expressed in the last decade regarding the iodine status of the UK and Irish populations. A study of Irish women in 2004 reported 55% of pregnant women in their sample population to be moderately iodine deficient and 53% of non-pregnant women to be moderately iodine deficient. A study of UK schoolgirls found that 51% were mildly iodine deficient and 16% were moderately deficient. Importantly, the prevalence of iodine deficiency was highest in Northern Ireland where 85% of those sampled were iodine deficient. Iodine is known to interact with selenium in the conversion of the thyroid hormone thyroxine (T4) to the metabolically active triiodothyonine (T3) hormone. Selenium is also important for immune, cardiovascular and cognitive function. Selenium status has been reported to be moderately low using pooled English data on blood selenium concentrations from 1984 to 1992. In addition, the latest National Diet and Nutrition Survey reports that selenium intakes are below recommendations for several population groups including women of childbearing age where mean selenium intakes are 76% of the recommended 60µg/day. This national survey also reported that 49% of women aged 19-64 years failed to meet the lower reference nutrient intake of 40µg/day. Milk and dairy products are the major source of iodine for the UK population and are also a source of selenium. The contribution of milk and dairy products to iodine and selenium intakes is greatest in adult females (35% and 6% respectively). Observational evidence has repeatedly reported milk consumption to be positively correlated with iodine status and iodine intakes. Research in Iceland and New Zealand has reported that milk consumption is not associated with selenium status; however it is unknown if this is true for the UK population. To date, no randomised controlled trial has examined the effect of milk consumption on either iodine or selenium status. The possibility of increasing iodine and selenium intake by increasing milk consumption, a widely available and consumed foodstuff, in a population group vulnerable to micronutrient deficiency should be investigated. This would add valuable data to the knowledge base for iodine, where there is ongoing debate over the most appropriate means of increasing iodine intake amongst women of childbearing age in the UK where salt iodisation, the key strategy in preventing deficiency, is not implemented. The aim of this study is to investigate the impact of cow's milk consumption on the biological status of iodine and selenium among women of child-bearing age. The study will be a 12 week randomised-controlled human intervention study. Participants will be randomised to consume additional semi-skimmed milk in the Following amounts, control group (0mls/day), intervention group (430mls/day or 3l per week).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 4, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 10, 2016

Completed
Last Updated

May 10, 2016

Status Verified

April 1, 2016

Enrollment Period

3 months

First QC Date

May 4, 2016

Last Update Submit

May 6, 2016

Conditions

Keywords

Cow's milkIodineSeleniumWomenChild-bearing age

Outcome Measures

Primary Outcomes (1)

  • Urinary iodine concentration

    Change from baseline following 12-week intervention

Secondary Outcomes (7)

  • Serum thyroid hormone analysis

    Baseline (week 0), mid (week 6) and post-intervention (week 12)

  • Urinary creatinine analysis

    Baseline (week 0), mid (week 6) and post-intervention (week 12)

  • Serum selenoprotein P analysis

    Baseline (week 0), mid (week 6) and post-intervention (week 12)

  • Dietary iodine and selenium intake

    Baseline (week 0), mid (week 6) and post-intervention (week 12)

  • Blood pressure

    Baseline (week 0), mid (week 6) and post-intervention (week 12)

  • +2 more secondary outcomes

Study Arms (2)

Milk treatment group

ACTIVE COMPARATOR

Semi-skimmed cow's milk + normal diet for 12 weeks

Other: Semi-skimmed cow's milk

Control group

NO INTERVENTION

Normal diet for 12 weeks

Interventions

430ml of semi-skimmed cow's milk / day for 12 weeks

Milk treatment group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy
  • Age 18-45 years
  • Females
  • Non smoking
  • No history of thyroid or gastrointestinal conditions
  • Not consuming thyroid medication or medication containing iodine or selenium
  • Willing to increase their milk consumption should they be randomised into the milk group

You may not qualify if:

  • Smoker
  • Pregnant, breastfeeding or planning to become pregnant during the study
  • Milk allergy
  • Non-milk consumers or vegans
  • Lactose intolerant individuals
  • Use of dietary supplements containing iodine or selenium in previous 3 months
  • Peri- or post-menopausal
  • Consume more than 250ml of milk daily

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Human Intervention Studies Unit, Ulster University

Coleraine, Co.Londonderry, BT52 1SA, United Kingdom

Location

Related Publications (1)

  • O'Kane SM, Pourshahidi LK, Mulhern MS, Strain JJ, Mackle EM, Koca D, Schomburg L, Hill S, O'Reilly J, Kmiotek D, Deitrich C, Bath SC, Yeates AJ. Cow Milk Consumption Increases Iodine Status in Women of Childbearing Age in a Randomized Controlled Trial. J Nutr. 2018 Mar 1;148(3):401-408. doi: 10.1093/jn/nxx043.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2016

First Posted

May 10, 2016

Study Start

September 1, 2015

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

May 10, 2016

Record last verified: 2016-04

Data Sharing

IPD Sharing
Will not share

Locations